BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Xiaomeng Hu, Tingting Wu, Xianya Qin, Yan Qi, Qi Qiao, Conglian Yang, Zhiping Zhang. Tumor Lysate-Loaded Lipid Hybrid Nanovaccine Collaborated with an Immune Checkpoint Antagonist for Combination ImmunotherapyAdvanced Healthcare Materials 2019; 8(1): 1800837 doi: 10.1002/adhm.201800837
2
E. M. Martinez, J. J. Cancela, T. S. Cuesta, X. X. Neira. Review. Use of psychrometers in field measurements of plant material: accuracy and handling difficultiesSpanish Journal of Agricultural Research 2011; 9(1): 313 doi: 10.5424/sjar/20110901-295-10
3
Daniel O Villarreal, Kendra T Talbott, Daniel K Choo, Devon J Shedlock, David B Weiner. Synthetic DNA vaccine strategies against persistent viral infectionsExpert Review of Vaccines 2013; 12(5): 537 doi: 10.1586/erv.13.33
4
Sk Md Fazle Akbar, Norio Horiike, Morikazu Onji. Immune therapy including dendritic cell based therapy in chronic hepatitis B virus infectionWorld Journal of Gastroenterology 2006; 12(18): 2876-2883 doi: 10.3748/wjg.v12.i18.2876
5
Liangen Chen, Zheng Zhang, Weiwei Chen, Zhidong Zhang, Yonggang Li, Ming Shi, Jiyuan Zhang, Lieping Chen, Shengdian Wang, Fu-Sheng Wang. B7-H1 Up-Regulation on Myeloid Dendritic Cells Significantly Suppresses T Cell Immune Function in Patients with Chronic Hepatitis BThe Journal of Immunology 2007; 178(10): 6634 doi: 10.4049/jimmunol.178.10.6634
6
Sheikh MF Akbar, Mamun Al-Mahtab, Sakirul I Khan, Ananta Shrestha, Shahina Tabassum, Yoichi Hiasa. Current trends in hepatitis B vaccinationFuture Virology 2016; 11(5): 369 doi: 10.2217/fvl-2016-0025
7
涛 巫. Immunotherapy for Chronic Hepatitis B Virus InfectionPharmacy Information 2019; 8(03): 105 doi: 10.12677/PI.2019.83013
8
M. Shi, S. Qian, W.-W. Chen, H. Zhang, B. Zhang, Z.-R. Tang, Z. Zhang, F.-S. Wang. Hepatitis B virus (HBV) antigen-pulsed monocyte-derived dendritic cells from HBV-associated hepatocellular carcinoma patients significantly enhance specific T cell responses in vitroClinical & Experimental Immunology 2006; 147(2): 277 doi: 10.1111/j.1365-2249.2006.03281.x
9
Olga Yu. Leplina, Tamara V. Tyrinova, Marina A. Tikhonova, Alexander A. Ostanin, Elena R. Chernykh. Interferon alpha induces generation of semi-mature dendritic cells with high pro-inflammatory and cytotoxic potentialCytokine 2015; 71(1): 1 doi: 10.1016/j.cyto.2014.07.258
10
Adam J. Gehring, June Ann D'Angelo. Dissecting the dendritic cell controversy in chronic hepatitis B virus infectionCellular & Molecular Immunology 2015; 12(3): 283 doi: 10.1038/cmi.2014.95
11
Y.-J. Ma, M. He, J.-A. Han, L. Yang, X.-Y. Ji. A Clinical Study of HBsAg-Activated Dendritic Cells and Cytokine-Induced Killer Cells During the Treatment for Chronic Hepatitis BScandinavian Journal of Immunology 2013; 78(4): 387 doi: 10.1111/sji.12097
12
Anthony Tanoto Tan, Sarene Koh, Vera Goh, Antonio Bertoletti. Understanding the immunopathogenesis of chronic hepatitis B virus: An Asian prospectiveJournal of Gastroenterology and Hepatology 2008; 23(6): 833 doi: 10.1111/j.1440-1746.2008.05385.x
13
Sheikh Mohammad Fazle Akbar, Mamun Al-Mahtab, Mohammad Helal Uddin, Md. Sakirul Islam Khan. HBsAg, HBcAg, and combined HBsAg/HBcAg-based therapeutic vaccines in treating chronic hepatitis B virus infectionHepatobiliary & Pancreatic Diseases International 2013; 12(4): 363 doi: 10.1016/S1499-3872(13)60057-0
14
Laís Teodoro da Silva, Bruna Tereso Santillo, Alexandre de Almeida, Alberto Jose da Silva Duarte, Telma Miyuki Oshiro. Using Dendritic Cell-Based Immunotherapy to Treat HIV: How Can This Strategy be Improved?Frontiers in Immunology 2018; 9 doi: 10.3389/fimmu.2018.02993
15
Jin Luo, Jun Li, Rui L. Chen, Lei Nie, Jie Huang, Zheng W. Liu, Lin Luo, Xiao J. Yan. Autologus dendritic cell vaccine for chronic hepatitis B carriers: A pilot, open label, clinical trial in human volunteersVaccine 2010; 28(13): 2497 doi: 10.1016/j.vaccine.2010.01.038
16
A. K. Vyas, A. Jindal, S. Hissar, G. Ramakrishna, N. Trehanpati. Immune balance in Hepatitis B Infection: Present and Future TherapiesScandinavian Journal of Immunology 2017; 86(1): 4 doi: 10.1111/sji.12553
17
Masanori Abe, Angus W. Thomson. Liver Immunology2007; : 49 doi: 10.1007/978-1-59745-518-3_5
18
Min Chen, Dazhi Zhang, Weiqun Zhen, Qingfeng Shi, Yi Liu, Ning Ling, Mingli Peng, Kaifu Tang, Peng Hu, Huaidong Hu, Hong Ren. Characteristics of Circulating T Cell Receptor γδ T Cells from Individuals Chronically Infected with Hepatitis B Virus (HBV): An Association between Vδ2 Subtype and Chronic HBV InfectionThe Journal of Infectious Diseases 2008; 198(11): 1643 doi: 10.1086/593065
19
Monique T. A. de Beijer, Diahann T. S. L. Jansen, Yingying Dou, Wim J. E. van Esch, Juk Yee Mok, Mariëlle J. P. Maas, Giso Brasser, Robert A. de Man, Andrea M. Woltman, Sonja I. Buschow, J.-H. James Ou. Discovery and Selection of Hepatitis B Virus-Derived T Cell Epitopes for Global Immunotherapy Based on Viral Indispensability, Conservation, and HLA-Binding StrengthJournal of Virology 2019; 94(7) doi: 10.1128/JVI.01663-19
20
Sheikh Mohammad Fazle Akbar, Mamun Al-Mahtab, Md. Sakirul Islam Khan. Non-antigen-specific and antigen-specific immune therapies for chronic hepatitis B: evidences from laboratory benches and patient's bedsidesExpert Opinion on Biological Therapy 2013; 13(7): 1063 doi: 10.1517/14712598.2013.789016
21
Ethel Atanley, Sylvia van Drunen Littel-van den Hurk. Future considerations for dendritic cell immunotherapy against chronic viral infectionsExpert Review of Clinical Immunology 2014; 10(6): 801 doi: 10.1586/1744666X.2014.907742
22
Jianqiang Li, Mengru Bao, Jun Ge, Sulin Ren, Tong Zhou, Fengchun Qi, Xiuying Pu, Jia Dou. Research progress of therapeutic vaccines for treating chronic hepatitis BHuman Vaccines & Immunotherapeutics 2017; 13(5): 986 doi: 10.1080/21645515.2016.1276125
23
Darren J. Wong, Stephen A. Locarnini, Alexander J.V. Thompson. Clinical Virology2016; : 713 doi: 10.1128/9781555819439.ch32
24
Rajan George, Allan Ma, Bruce Motyka, Yuenian Eric Shi, Qiang Liu, Philip Griebel. A dendritic cell-targeted chimeric hepatitis B virus immunotherapeutic vaccine induces both cellular and humoral immune responses in vivoHuman Vaccines & Immunotherapeutics 2020; 16(4): 779 doi: 10.1080/21645515.2019.1689081
25
Vinod K Rustgi, Raymond S Koff. Future therapy for hepatitis BFuture Virology 2007; 2(1): 79 doi: 10.2217/17460794.2.1.79
26
Sheikh Mohammad Fazle Akbar, Mamun Al-Mahtab, Yoichi Hiasa. Designing Immune Therapy for Chronic Hepatitis BJournal of Clinical and Experimental Hepatology 2014; 4(3): 241 doi: 10.1016/j.jceh.2014.06.008
27
Wei Zhao, Wangying Hu, Xiaolong Wang, Nan Xia, Qixiang Hu, Hua Zhou. A traditional Chinese medicine, Lujiao prescription, as a potential therapy for hypertrophic cardiomyocytes by acting on histone acetylationJournal of the Chinese Medical Association 2015; 78(8): 486 doi: 10.1016/j.jcma.2015.03.006
28
Laura Ochoa-Callejero, Pedro Berraondo, Julien Crettaz, Cristina Olagüe, África Vales, Juan Ruiz, Jesús Prieto, Bud C. Tennant, Stephan Menne, Gloria González-Aseguinolaza. Woodchuck dendritic cells generated from peripheral blood mononuclear cells and transduced with recombinant human adenovirus serotype 5 induce antigen-specific cellular immune responsesJournal of Medical Virology 2007; 79(5): 522 doi: 10.1002/jmv.20808
29
Yin Huang, Zhi Chen, Hongyu Jia, Wei Wu, Shigen Zhong, Cheng Zhou. Induction of Tc1 response and enhanced cytotoxic T lymphocyte activity in mice by dendritic cells transduced with adenovirus expressing HBsAgClinical Immunology 2006; 119(3): 280 doi: 10.1016/j.clim.2006.01.015
30
Fu-Sheng Wang. Clinical immune characterization of hepatitis B virus infection and implications for immune intervention: Progress and challengesHepatology Research 2007; 37(s3): S339 doi: 10.1111/j.1872-034X.2007.00222.x
31
David C. Jackson, Georgia Deliyannis, Emily Eriksson, Irene Dinatale, Michael Rizkalla, Eric J. Gowans. Dendritic Cell Immunotherapy of Hepatitis C Virus Infection: Toxicology of Lipopeptide-Loaded Dendritic CellsInternational Journal of Peptide Research and Therapeutics 2005; 11(4): 223 doi: 10.1007/s10989-005-9270-y
32
Norihisa Sakamoto, Kazuhide Tsuji, Linda M. Muul, Ann M. Lawler, Emanuel F. Petricoin, Fabio Candotti, Julia A. Metcalf, Jorge A. Tavel, H. Clifford Lane, Walter J. Urba, Bernard A. Fox, Ajit Varki, Joan K. Lunney, Amy S. Rosenberg. Bovine apolipoprotein B-100 is a dominant immunogen in therapeutic cell populations cultured in fetal calf serum in mice and humansBlood 2007; 110(2): 501 doi: 10.1182/blood-2007-01-066522
33
Mei-Juan Wei, Xing-Nan Pan, Kai-Peng Wei, Xu-Hong Li, Xiao-Long Liu, Xiao-Man Zhang, Ya-Ling Jiang, Chun-Yu Zhang, Jian-Kun Shen. Efficacy of HBV-pulsed DCs in combination with entecavir in patients with chronic hepatitis B infectionInternational Immunopharmacology 2015; 27(2): 238 doi: 10.1016/j.intimp.2015.06.019
34
Sheikh Mohammad Fazle Akbar, Mamun Al-Mahtab, Munira Jahan, Osamu Yoshida, Yoichi Hiasa. Novel insights into immunotherapy for hepatitis B patientsExpert Review of Gastroenterology & Hepatology 2016; 10(2): 267 doi: 10.1586/17474124.2016.1112266
35
Nathalie Cools, Annacarmen Petrizzo, Evelien Smits, Franco M Buonaguro, Maria L Tornesello, Zwi Berneman, Luigi Buonaguro. Dendritic cells in the pathogenesis and treatment of human diseases: a Janus Bifrons?Immunotherapy 2011; 3(10): 1203 doi: 10.2217/imt.11.110
36
Mehdi Ghasemi, Murat Erturk, Kurtulus Buruk, Mehmet Sonmez. Induction of potent protection against acute and latent herpes simplex virus infection in mice vaccinated with dendritic cellsCytotherapy 2013; 15(3): 352 doi: 10.1016/j.jcyt.2012.11.012
37
Hai-hua Sun, Dong-fang Zhou, Jun-ying Zhou. The role of DCs in the immunopathogenesis of chronic HBV infection and the methods of inducing DCs maturationJournal of Medical Virology 2016; 88(1): 13 doi: 10.1002/jmv.24306
38
Prakriti Sinha, Parul Sahu. Dynamics of Immune Activation in Viral Diseases2020; : 205 doi: 10.1007/978-981-15-1045-8_14